NCT06652503 The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program
| NCT ID | NCT06652503 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nova Southeastern University |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2025-01-13 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2025-01-13 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to provide a free 6-week, online psychological coaching program to NSU undergraduate students to help with anxiety, depression, and stress, while improving quality of life and healthy coping skills.
Eligibility Criteria
Inclusion Criteria: * Currently matriculating NSU undergraduate students (ages 18+) Exclusion Criteria: * Students who are not current NSU undergrads, participants aged 17 and younger, students who are currently enrolled in psychotherapy or mental health services, or students with acute mental health needs (e.g., psychosis, active alcohol or substance use problems, suicidality)
Contact & Investigator
Kayla Thayer, Ph.D., ABPP
PRINCIPAL INVESTIGATOR
Nova Southeastern University
Frequently Asked Questions
Who can join the NCT06652503 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06652503 currently recruiting?
Yes, NCT06652503 is actively recruiting participants. Contact the research team at kthayer@nova.edu for enrollment information.
Where is the NCT06652503 trial being conducted?
This trial is being conducted at Fort Lauderdale, United States.
Who is sponsoring the NCT06652503 clinical trial?
NCT06652503 is sponsored by Nova Southeastern University. The principal investigator is Kayla Thayer, Ph.D., ABPP at Nova Southeastern University. The trial plans to enroll 160 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.